[1] Bousquet J, Anto J M, Bachert C, et al. Allergic rhinitis[J]. Nat Rev Dis Primers, 2020, 6(1): 95. [2] 中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组, 中华医学会耳鼻咽喉头颈外科学分会鼻科学组. 中国变应性鼻炎诊断和治疗指南(2022年,修订版)[J]. 中华耳鼻咽喉头颈外科杂志, 2022, 57(2): 106-129. [3] Fokkens W J, Lund V J, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020[J]. Rhinology, 2020, 58(Suppl S29): 1-464. [4] Schleimer R P. Immunopathogenesis of chronic rhinosinusitis and nasal polyposis[J]. Annu Rev Pathol, 2017, 12: 331-357. [5] 中华医学会呼吸病学分会哮喘学组. 支气管哮喘防治指南(2020年版)[J]. 中华结核和呼吸杂志, 2020, 43(12): 1023-1048. [6] Anushiravani M, Bakhshaee M, Taghipour A, et al. A systematic review of randomized controlled trials with herbal medicine on chronic rhinosinusitis[J]. Phytother Res, 2018, 32(3): 395-401. [7] Li-Weber M. New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents wogonin, baicalein and baicalin[J]. Cancer Treat Rev, 2009, 35(1): 57-68. [8] Zhao Q, Chen X Y, Martin C. Scutellaria baicalensis, the golden herb from the garden of Chinese medicinal plants[J]. Sci Bull (Beijing), 2016, 61(18): 1391-1398. [9] Liu W, Wang H L, Zhu B, et al. An activity-integrated strategy of the identification, screening and determination of potential neuraminidase inhibitors from Radix Scutellariae[J]. PLoS One, 2017, 12(5): e0175751. [10] Donald G, Hertzer K, Eibl G. Baicalein—an intriguing therapeutic phytochemical in pancreatic cancer[J]. Curr Drug Targets, 2012, 13(14): 1772-1776. [11] Dinda B, Dinda S, DasSharma S, et al. Therapeutic potentials of baicalin and its aglycone, baicalein against inflammatory disorders[J]. Eur J Med Chem, 2017, 131: 68-80. [12] 潘刚强, 袁岳沙, 陈杰, 等. Th1/Th2细胞因子在过敏性鼻炎患者表达水平研究[J]. 检验医学与临床, 2010, 7(22): 2472-2473. [13] 黄丰, 童晓云, 邓华明, 等. 黄芩苷调节哮喘模型小鼠Th1/th2反应机制初探[J]. 中药材, 2009, 32(9): 1407-1410. [14] Bui T T, Piao C H, Song C H, et al. Baicalein, wogonin, and Scutellaria baicalensis ethanol extract alleviate ovalbumin-induced allergic airway inflammation and mast cell-mediated anaphylactic shock by regulation of Th1/Th2 imbalance and histamine release[J]. Anat Cell Biol, 2017, 50(2): 124-134. [15] Ma C H, Ma Z Q, Fu Q, et al. Anti-asthmatic effects of baicalin in a mouse model of allergic asthma[J]. Phytother Res, 2014, 28(2): 231-237. [16] Huang X K, Chen Y L, Zhang F C, et al. Peripheral th17/treg cell-mediated immunity imbalance in allergic rhinitis patients[J]. Braz J Otorhinolaryngol, 2014, 80(2): 152-155. [17] 王娅, 王悦, 马永明, 等. Th9和Th17及Treg细胞在鼻息肉发病中的研究与探讨[J]. 临床耳鼻咽喉头颈外科杂志, 2016, 30(4): 1001-1781. [18] 武大伟, 宋倩. Th17/Treg细胞失衡在嗜酸粒细胞性慢性鼻-鼻窦炎伴鼻息肉黏膜重塑中的作用[J]. 临床耳鼻咽喉头颈外科杂志, 2014, 28(20): 1001-1781. [19] Zou X L, Chen Z G, Zhang T T, et al. Th17/Treg homeostasis, but not Th1/Th2 homeostasis, is implicated in exacerbation of human bronchial asthma[J]. Ther Clin Risk Manag, 2018, 14: 1627-1636. [20] 谭倩, 刘志丹, 李晓燕, 等. Th17/Treg细胞失衡在变应性鼻炎中的作用研究进展[J]. 中国免疫学杂志, 2017, 33(4): 638-642. [21] Li J, Li Y. Autophagy is involved in allergic rhinitis by inducing airway remodeling[J]. Int Forum Allergy Rhinol, 2019, 9(11): 1346-1351. [22] Li J, Lin X Y, Liu X, et al. Baicalin regulates Treg/Th17 cell imbalance by inhibiting autophagy in allergic rhinitis[J]. Mol Immunol, 2020, 125: 162-171. [23] Yang M, Zhu X Y, Fu F D, et al. Baicalin ameliorates inflammatory response in a mouse model of rhinosinusitis via regulating the Treg/Th17 balance[J]. Ear Nose Throat J, 2022, 101(2_suppl): 8S-16S. [24] 王平. 黄芩苷对过敏性哮喘小鼠Th17/Treg反应失衡的调节作用研究[D]. 延吉: 延边大学, 2016. [25] Tak P P, Firestein G S. NF-κB: a key role in inflammatory diseases[J]. J Clin Invest, 2001, 107(1): 7-11. [26] Xu R, Xu G, Shi J, et al. A correlative study of NF-κB activity and cytokines expression in human chronic nasal sinusitis[J]. J Laryngol Otol, 2007, 121(7): 644-649. [27] Höpken U E, Foss H D, Meyer D, et al. Up-regulation of the chemokine receptor CCR7 in classical but not in lymphocyte-predominant Hodgkin disease correlates with distinct dissemination of neoplastic cells in lymphoid organs[J]. Blood, 2002, 99(4): 1109-1116. [28] Liu J Q, Wei Y, Luo Q L, et al. Baicalin attenuates inflammation in mice with OVA-induced asthma by inhibiting NF-κB and suppressing CCR7/CCL19/CCL21[J]. Int J Mol Med, 2016, 38(5): 1541-1548. [29] Hsieh C J, Hall K, Ha T Z, et al. Baicalein inhibits IL-1β-and TNF-α-induced inflammatory cytokine production from human mast cells via regulation of the NF-κB pathway[J]. Clin Mol Allergy, 2007, 5(1): 5. [30] Stevens W W, Kato A. Group 2 innate lymphoid cells in nasal polyposis[J]. Ann Allergy Asthma Immunol, 2021, 126(2): 110-117. [31] Poposki J A, Klingler A I, Tan B K, et al. Group 2 innate lymphoid cells are elevated and activated in chronic rhinosinusitis with nasal polyps[J]. Immun Inflamm Dis, 2017, 5(3): 233-243. [32] Yoshida K, Takabayashi T, Kaneko A, et al. Baicalin suppresses type 2 immunity through breaking off the interplay between mast cell and airway epithelial cell[J]. J Ethnopharmacol, 2021, 267: 113492. [33] Chen S Z, Chen G R, Shu S, et al. Metabolomics analysis of baicalin on ovalbumin-sensitized allergic rhinitis rats[J]. R Soc Open Sci, 2019, 6(2): 181081. |